FDA Inspection 658026 — Lydie L. Hazan, M.D.

Lydie L. Hazan, M.D. — FEI 3005993434

The FDA completed an inspection of Lydie L. Hazan, M.D. on April 26, 2010 in Los Angeles, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 26, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Los Angeles, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
755221 CFR 312.66Changes in research